A Talk with Principal at DeciBio to Find Out
- how biotech consultant works
Andrew Aijian, PhD
Wednesday, February 27, 2019
Andrew Aijian is a life sciences professional engaged in strategy development and market analysis for the life science research, diagnostic, biotechnology, and healthcare industries. Andrew’s interests and expertise include cancer immunotherapy, emerging technology development and commercialization, personalized/ precision medicine, disruptive healthcare products and services, regenerative medicine, -omics tools, lab-on-a-chip technologies, and STEM education.
Andrew is a principal at DeciBio, a consulting company exclusively focusing on life science field. Andrew has been working at DeciBio for six years. He will share real-life examples or case studies, the daily life as a consultant, and career development advice for graduate students.